Breaking News Instant updates and real-time market news.

PIRS

Pieris Pharmaceuticals

$4.65

-0.09 (-1.90%)

, SNY

Sanofi

$42.96

0.03 (0.07%)

07:38
09/03/19
09/03
07:38
09/03/19
07:38

Pieris Pharmaceuticals appoints Kaufmann as CSO, says CFO Reine to depart

Pieris Pharmaceuticals (PIRS) announced the appointment of Hitto Kaufmann, Ph.D. as Senior Vice President and Chief Scientific Officer and the departure of Allan Reine, M.D., Senior Vice President and CFO. Kaufmann will be responsible for the company's drug discovery, protein engineering and biomanufacturing activities, while overseeing alliance management and serving as site head for its German R&D facility. Prior to joining Pieris, Dr. Kaufmann spent five years at Sanofi (SNY), where he held several executive positions in Industrial Affairs and R&D. Additionally, Dr. Reine will be stepping down from the company later this month to pursue another business opportunity. Dr. Reine will continue to advise the company until the end of the year, at which time Pieris intends to initiate a search to identify a new CFO. Upon Dr. Reine's resignation, Tom Bures, Pieris' Vice President of Finance will serve as the company's Treasurer and Principal Financial and Accounting Officer.

PIRS

Pieris Pharmaceuticals

$4.65

-0.09 (-1.90%)

SNY

Sanofi

$42.96

0.03 (0.07%)

  • 04

    Sep

  • 04

    Sep

  • 09

    Sep

  • 09

    Sep

  • 16

    Sep

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

PIRS Pieris Pharmaceuticals
$4.65

-0.09 (-1.90%)

05/13/19
BARD
05/13/19
INITIATION
Target $5
BARD
Outperform
Pieris Pharmaceuticals initiated with an Outperform at Baird
Baird analyst Madhu Kumar initiated Pieris Pharmaceuticals with an Outperform and $5 price target.
05/14/19
BARD
05/14/19
INITIATION
Target $5
BARD
Outperform
Pieris Pharmaceuticals initiated with an Outperform at Baird
Baird analyst Madhu Kumar initiated Pieris Pharmaceuticals with an Outperform rating and $5 price target, saying he believe's Pieris' anticalin platform has the potential to disrupt biologic therapies in the respiratory and oncology spaces. The analyst called out the company's Phase 1 single ascending dose results for anti-interleukin-4 receptor a Ac PRS060 as potentially validating the drug's utility in asthma and serve as a positive catalyst for shares.
07/29/19
WBLR
07/29/19
NO CHANGE
WBLR
Outperform
Updates 'very positive' for upcoming Pieris presentation, says William Blair
Pieris Pharmaceuticals (PIRS) will present Phase Ib safety and efficacy results with PRS-060, an inhaled IL-4R alpha inhibitor, at the upcoming European Respiratory Society International Congress, held September 28 through October 2, William Blair analyst Matt Phipps tells investors in a research note. The poster presentation to be presented on October 1 is titled, "Multiple ascending dose study of the inhaled IL-4Ra antagonist, AZD1402/PRS-060, in mild asthmatics demonstrates robust FeNO reduction and a promising clinical profile for the treatment of asthma," the analyst point out. In addition, AstraZeneca (AZN) plans to initiate a Phase II trial with AZD1402/PRS-060 in the second half of this year, according to its recent earnings presentation, adds Phipps. He views these updates as "very positive" for the upcoming presentation, and believes PRS-060 has "significant potential" in the treatment of asthma patients. Phipps keeps an Outperform rating on Pieris Pharmaceuticals.
07/30/19
BARD
07/30/19
DOWNGRADE
Target $5
BARD
Neutral
Pieris Pharmaceuticals downgraded to Neutral from Outperform at Baird
Baird analyst Madhu Kumar downgraded Pieris Pharmaceuticals to Neutral from Outperform with an unchanged price target of $5.
SNY Sanofi
$42.96

0.03 (0.07%)

08/14/19
UBSW
08/14/19
UPGRADE
UBSW
Buy
Sanofi upgraded to Buy from Neutral at UBS
UBS upgraded Sanofi to Buy from Neutral and raised its price target for the shares to 87 euros from 79 euros.
08/14/19
UBSW
08/14/19
UPGRADE
UBSW
Buy
UBS upgrades Sanofi to Buy on turnaround prospects
UBS analyst Laura Sutcliffe upgraded Sanofi to Buy from Neutral and raised her price target for the shares to 87 euros from 79 euros. The analyst sees signs of a turnaround for the company and believes its pipeline can fixed ahead of patent expiration. She expects mid-single-digit sales growth for rate diseases and vaccines through 2023 as well as success for Dupixent.
08/14/19
08/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Evercore Partners (EVR) upgraded to Neutral from Sell at Goldman Sachs with analyst Richard Ramsden saying believes that stronger U.S. large cap deal activity than he previously expected should support Evercore's revenues. 2. Sanofi (SNY) upgraded to Buy from Neutral at UBS with analyst Laura Sutcliffe saying she sees signs of a turnaround for the company and believes its pipeline can fixed ahead of patent expiration. 3. Bristol-Myers (BMY) upgraded to Overweight from Neutral at Atlantic Equities. 4. Horizon Pharma (HZNP) upgraded to Outperform from Market Perform at BMO Capital with analyst Gary Nachman citing the company's "strong" Q2 results driven by Krystexxa. 5. Ferrari (RACE) upgraded to Buy from Neutral at Goldman Sachs with analyst George Galliers citing the company's Q2 results earlier this month. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/03/19
BERN
09/03/19
INITIATION
Target $52
BERN
Outperform
Sanofi initiated with an Outperform at Bernstein
Bernstein analyst Wimal Kapadia initiated Sanofi with an Outperform and $52 price target.

TODAY'S FREE FLY STORIES

MRK

Merck

$85.17

(0.00%)

, LLY

Eli Lilly

$116.16

(0.00%)

09:41
09/23/19
09/23
09:41
09/23/19
09:41
Conference/Events
Cantor Fitzgerald biotech analysts to hold KOL analyst/industry conference call »

Analysts, along with Key…

MRK

Merck

$85.17

(0.00%)

LLY

Eli Lilly

$116.16

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

  • 02

    Oct

  • 02

    Oct

  • 02

    Oct

  • 03

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 14

    Mar

AMD

AMD

$30.04

(0.00%)

, NKE

Nike

$86.69

(0.00%)

09:40
09/23/19
09/23
09:40
09/23/19
09:40
Options
Unusually active option classes on open September 23rd »

Unusual total active…

AMD

AMD

$30.04

(0.00%)

NKE

Nike

$86.69

(0.00%)

SLV

iShares Silver Trust

$16.80

(0.00%)

GDX

VanEck Vectors Gold Miners ETF

$28.67

(0.00%)

XLNX

Xilinx

$96.45

(0.00%)

AMAT

Applied Materials

$50.92

(0.00%)

MRK

Merck

$85.17

(0.00%)

X

U.S. Steel

$10.81

(0.00%)

WORK

Slack Technologies

$25.39

(0.00%)

BMY

Bristol-Myers

$50.56

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 02

    Oct

  • 02

    Oct

  • 03

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 31

    Oct

  • 07

    Nov

  • 14

    Mar

FB

Facebook

$189.88

-0.27 (-0.14%)

, SNAP

Snap

$17.05

0.18 (1.07%)

09:39
09/23/19
09/23
09:39
09/23/19
09:39
Periodicals
Snap detailed Facebook's hardball tactics in 'Voldemort' dossier, WSJ reports »

Facebook's (FB)…

FB

Facebook

$189.88

-0.27 (-0.14%)

SNAP

Snap

$17.05

0.18 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

FNKO

Funko

$21.88

-1.48 (-6.34%)

09:37
09/23/19
09/23
09:37
09/23/19
09:37
Recommendations
Funko analyst commentary  »

DA Davidson reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APY

Apergy

$29.42

0.07 (0.24%)

, BAS

Basic Energy

$1.89

0.45 (31.25%)

09:36
09/23/19
09/23
09:36
09/23/19
09:36
Conference/Events
Johnson Rice to hold a conference »

Energy Conference will be…

APY

Apergy

$29.42

0.07 (0.24%)

BAS

Basic Energy

$1.89

0.45 (31.25%)

CHAP

Chaparral Energy

$1.77

-0.025 (-1.39%)

DNR

Denbury Resources

$1.29

-0.045 (-3.38%)

EPM

Evolution Petroleum

$5.88

0.23 (4.07%)

FET

Forum Energy

$1.75

-0.04 (-2.23%)

GDP

Goodrich Petroleum

$11.14

0.04 (0.36%)

HLX

Helix Energy

$8.28

-0.145 (-1.72%)

ICD

Independence Contract Drilling

$1.73

0.14 (8.81%)

KEG

Key Energy

$1.60

-0.015 (-0.93%)

LLEX

Lilis Energy

$0.39

0.0095 (2.52%)

MDR

McDermott

$2.01

0.43 (27.22%)

NBL

Noble Energy

$23.15

-0.15 (-0.64%)

OAS

Oasis Petroleum

$3.95

0.01 (0.25%)

PDCE

PDC Energy

$30.46

-1.06 (-3.36%)

REI

Ring Energy

$1.82

0.23 (14.51%)

RE

Everest Re

$264.50

2.26 (0.86%)

SBOW

SilverBow Resources

$10.29

-0.21 (-2.00%)

SDPI

Superior Drilling

$0.83

-0.004 (-0.48%)

TUSK

Mammoth Energy

$2.98

0.03 (1.02%)

USWS

U.S. Well Services

$2.17

-0.12 (-5.24%)

WTTR

Select Energy Services

$9.02

0.11 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 23

    Sep

  • 25

    Sep

  • 02

    Oct

  • 02

    Oct

  • 29

    Oct

  • 07

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

BAC

Bank of America

$29.57

-0.23 (-0.77%)

, BK

BNY Mellon

$46.38

-0.61 (-1.30%)

09:35
09/23/19
09/23
09:35
09/23/19
09:35
Conference/Events
U.S. Treasury Department to co-host a conference »

The U.S. Treasury Dept,…

BAC

Bank of America

$29.57

-0.23 (-0.77%)

BK

BNY Mellon

$46.38

-0.61 (-1.30%)

BLK

BlackRock

$444.61

0.64 (0.14%)

CS

Credit Suisse

$12.81

-0.05 (-0.39%)

FNMA

Fannie Mae

$0.00

(0.00%)

GS

Goldman Sachs

$213.76

-1.59 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 27

    Oct

09:35
09/23/19
09/23
09:35
09/23/19
09:35
General news
Breaking General news story  »

New York Federal Reserve…

HUN

Huntsman

$22.49

-0.3 (-1.32%)

09:34
09/23/19
09/23
09:34
09/23/19
09:34
Upgrade
Huntsman rating change  »

Huntsman upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

NFLX

Netflix

$270.66

-15.92 (-5.56%)

09:33
09/23/19
09/23
09:33
09/23/19
09:33
Recommendations
Netflix analyst commentary  »

Release of The Irishman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 16

    Oct

GEL

Genesis Energy

$22.27

-0.43 (-1.89%)

09:32
09/23/19
09/23
09:32
09/23/19
09:32
Hot Stocks
Genesis Energy announces expansion of existing sodium services operations »

Genesis Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
09/23/19
09/23
09:30
09/23/19
09:30
General news
PMI Composite FLASH Manufacturing â€' Level to be reported at 09:45 »

September PMI Composite…

09:30
09/23/19
09/23
09:30
09/23/19
09:30
General news
PMI Composite FLASH â€' Level to be reported at 09:45 »

September PMI Composite…

SEV

Sevcon

$0.00

(0.00%)

, XYL

Xylem

$77.61

-0.38 (-0.49%)

09:29
09/23/19
09/23
09:29
09/23/19
09:29
Conference/Events
RBC Capital to hold booth tours and meetings at conference »

RBC Capital Company Booth…

SEV

Sevcon

$0.00

(0.00%)

XYL

Xylem

$77.61

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 31

    Oct

MED

Medifast

$108.05

1.52 (1.43%)

09:28
09/23/19
09/23
09:28
09/23/19
09:28
Recommendations
Medifast analyst commentary  »

Medifast CFO confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FELE

Franklin Electric

$46.86

-0.66 (-1.39%)

, WTS

Watts Water

$95.13

-0.94 (-0.98%)

09:28
09/23/19
09/23
09:28
09/23/19
09:28
Conference/Events
Seaport Global to hold booth tours at conference »

Seaport Global Company…

FELE

Franklin Electric

$46.86

-0.66 (-1.39%)

WTS

Watts Water

$95.13

-0.94 (-0.98%)

XYL

Xylem

$77.61

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 31

    Oct

  • 18

    Nov

FSLR

First Solar

$66.69

-0.4 (-0.60%)

09:27
09/23/19
09/23
09:27
09/23/19
09:27
Hot Stocks
First Solar announces 25GW DC of photovoltaic modules shipped »

First Solar is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:27
09/23/19
09/23
09:27
09/23/19
09:27
Conference/Events
Water Environment Federation to hold a conference »

WEFTEC 2019 will be held…

09:26
09/23/19
09/23
09:26
09/23/19
09:26
Conference/Events
Barclays to hold a forum »

Payments & FinTech…

ADBE

Adobe

$277.84

-3.37 (-1.20%)

, ADP

ADP

$159.15

-0.15 (-0.09%)

09:26
09/23/19
09/23
09:26
09/23/19
09:26
Conference/Events
PagerDuty to hold a summit »

PagerDuty Summit 2019…

ADBE

Adobe

$277.84

-3.37 (-1.20%)

ADP

ADP

$159.15

-0.15 (-0.09%)

AMZN

Amazon.com

$1,793.64

-28.57 (-1.57%)

GOOG

Alphabet

$1,229.57

-10.03 (-0.81%)

IBM

IBM

$141.82

-1.17 (-0.82%)

MSFT

Microsoft

$139.34

-1.74 (-1.23%)

TWLO

Twilio

$114.39

-0.74 (-0.64%)

UBER

Uber

$32.52

-1.31 (-3.87%)

WORK

Slack Technologies

$25.39

-0.375 (-1.46%)

ZEN

Zendesk

$77.73

0.275 (0.36%)

ZM

Zoom Video

$82.68

-1.91 (-2.26%)

PD

PagerDuty

$29.89

0.785 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 13

    Nov

FQVLF

First Quantum Minerals

$0.00

(0.00%)

09:25
09/23/19
09/23
09:25
09/23/19
09:25
Hot Stocks
First Quantum granted right to enter option agreement on Dragonslayer project »

Millrock Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVCY

Central Valley Community

$21.49

0.88 (4.27%)

09:24
09/23/19
09/23
09:24
09/23/19
09:24
Downgrade
Central Valley Community rating change  »

Central Valley Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIVE

Five Below

$126.54

-1.89 (-1.47%)

09:23
09/23/19
09/23
09:23
09/23/19
09:23
Recommendations
Five Below analyst commentary  »

Five Below's Ten…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$154.15

0.73 (0.48%)

09:22
09/23/19
09/23
09:22
09/23/19
09:22
Hot Stocks
Hershey completes acquisition of ONE Brands for $397M »

The Hershey Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Healthcare

$124.35

-2.51 (-1.98%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Hot Stocks
HCA Healthcare CHRO John Steele to retire, Jennifer Berres to succeed »

HCA Healthcare announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

REGN

Regeneron

$295.79

9.51 (3.32%)

, SNY

Sanofi

$46.50

1.61 (3.59%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Upgrade
Regeneron, Sanofi, Roche rating change  »

Guggenheim upgrades…

REGN

Regeneron

$295.79

9.51 (3.32%)

SNY

Sanofi

$46.50

1.61 (3.59%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

  • 04

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.